Clinical Applications of CD34+ Peripheral Blood Progenitor Cells (PBPC)

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Stem Cells

• Publication date

  2000-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1634/stemcells.18-2-87PMID 10742380
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy.

  1999cited by this paper
• Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation.

  1999cited by this paper
• Clinical and molecular follow-up by amplification of the CDR-III IgH region in multiple myeloma patients after autologous transplantation of hematopoietic CD34+ stem cells.

  1999cited by this paper
• Transplantation of Megadoses of Purified Haploidentical Stem Cells

  1999cited by this paper
• Autologous Peripheral Blood Progenitor Cell Transplantation in Multiple Myeloma

  1999cited by this paper
• Immune reconstitution following allogeneic peripheral blood progenitor cell transplantation: comparison of recipients of positive CD34+ selected grafts with recipients of unmanipulated grafts.

  1999cited by this paper
• Clinical scale isolation of highly purified peripheral CD34+progenitors for autologous and allogeneic transplantation in children

  1999cited by this paper
• Complete molecular remissions induced by patient-specific vaccination plus granulocyte–monocyte colony-stimulating factor against lymphoma

  1999cited by this paper
• Autografting with CD34+ peripheral blood stem cells: retained engraftment capability and reduced tumour cell content

  1999cited by this paper
• Idiotype Vaccination Using Dendritic Cells After Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma—A Feasibility Study

  1999cited by this paper
• CD34+‐selected peripheral blood progenitor cell transplantation in patients with multiple myeloma: tumour cell contamination and outcome

  1999cited by this paper
• Increased Incidence of Cytomegalovirus Disease After Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation

  1999cited by this paper
• Ex-vivo expansion of hematopoietic progenitor cells: preliminary results in breast cancer.

  1999cited by this paper
• Abrogation of post-myeloablative chemotherapy neutropenia by ex-vivo expanded autologous CD34-positive cells.

  1999cited by this paper
• Efficacy and safety of simultaneous immunomagnetic CD34+ cell selection and breast cancer cell purging in peripheral blood progenitor cell samples used for hematopoietic rescue after high-dose therapy.

  1999cited by this paper
• Intensive therapy in multiple myeloma.

  1999cited by this paper
• Idiotype vaccination using dendritic cells after autologous peripheral blood stem cell transplantation for multiple myeloma--a feasibility study.

  1999cited by this paper
• Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood

  1999cited by this paper
• Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF alone.

  1999cited by this paper
• Collection, tumor contamination, and engraftment kinetics of highly purified hematopoietic progenitor cells to support high dose therapy in multiple myeloma.

  1998cited by this paper
• Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.

  1998cited by this paper
• Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.

  1998cited by this paper
• Autologous transplantation of mobilized peripheral blood CD34+ cells selected by immunomagnetic procedures in patients with multiple myeloma

  1998cited by this paper
• Isolation of CD34+ cells from blood stem cell components using the Baxter Isolex system

  1998cited by this paper
• Ex vivo expansion of hematopoietic progenitor cells for clinical use.

  1998cited by this paper
• Large-Scale Isolation of CD34+ Cells Using the Amgen Cell Selection Device Results in High Levels of Purity and Recovery

  1997cited by this paper
• A prospective randomized trial of buffy coat versus CD34-selected autologous bone marrow support in high-risk breast cancer patients receiving high-dose chemotherapy.

  1997cited by this paper
• Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood.

  1997cited by this paper
• Autologous stem cell transplantation for autoimmune diseases: issues in protocol development.

  1997cited by this paper
• Combined positive/negative selection for highly effective purging of PBPC grafts: towards clinical application in patients with B-CLL

  1997cited by this paper
• Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients.

  1997cited by this paper
• Comparison between Bone Marrow and G‐CSF‐Mobilized Peripheral Blood Allografts Undergoing Clinical Scale CD34+ Cell Selection

  1996cited by this paper
• Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.

  1996cited by this paper
• Transplantation of CD34+ hematopoietic progenitor cells.

  1996cited by this paper
• Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer.

  1996cited by this paper
• Large-Scale Selection of CD34+ Peripheral Blood Progenitors and Expansion of Neutrophil Precursors for Clinical Applications

  1996cited by this paper
• A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome.

  1996cited by this paper
• Allogeneic transplantation of positively selected peripheral blood CD34+ progenitor cells from matched related donors.

  1996cited by this paper
• Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell support

  1996cited by this paper
• CD34+ Progenitor Cell Selection: Clinical Transplantation, Tumor Cell Purging, Gene Therapy, Ex Vivo Expansion, and Cord Blood Processing

  1996cited by this paper
• Second transplantation with CD34+ bone marrow cells selected from a two‐loci HLA‐mismatched sibling for a patient with chronic myeloid leukaemia

  1996cited by this paper
• Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy.

  1996cited by this paper
• Successful engraftment of allogeneic CD34-enriched marrow cell transplantation from HLA-mismatched parental donors.

  1996cited by this paper
• A Prospective, Randomized Trial of Autologous Bone Marrow Transplantation and Chemotherapy in Multiple Myeloma

  1996cited by this paper
• Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo.

  1995cited by this paper
• Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells.

  1994cited by this paper
• Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin

  1994cited by this paper
• Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors [see comments]

  1994cited by this paper
• Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin.

  1994cited by this paper
• Detection and viability of tumor cells in peripheral blood stem cell and bone marrow collections from breast cancer patients.

  1994cited by this paper
• Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.

  1994cited by this paper
• Transplantation of CD34+ marrow and/or PBPCS into breast cancer patients following high-dose chemotherapy

  1994cited by this paper
• Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment.

  1994cited by this paper
• Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques.

  1993cited by this paper
• Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.

  1993cited by this paper
• Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus.

  1993cited by this paper
• Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma.

  1991cited by this paper
• Effect of HLA incompatibility on graft-versus-host disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma.

  1990cited by this paper
• Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors.

  1990cited by this paper

• Purging myeloma cell contaminants and simultaneous expansion of peripheral blood mobilised stem cells.

  2023cites this paper
• Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy

  2021cites this paper
• Human CD34-negative Hematopoietic Stem Cells: The Current Understanding of Their Biological Nature.

  2021cites this paper
• Efficient and nontoxic biomolecule delivery to primary human hematopoietic stem cells using nanostraws

  2020cites this paper
• Impact of the CD4:CD8 ratio in bone marrow on stem cell mobilization and engraftment in autologous stem cell transplant patients

  2020cites this paper
• CD34 cells in somatic, regenerative and cancer stem cells: Developmental biology, cell therapy, and omics big data perspective

  2019cites this paper
• Monopoiesis in humans and mice

  2018cites this paper
• Automated, spinning membrane filtration for preparation of mobilized leukapheresis products for CD34+ cell selection

  2017cites this paper
• Purification of progenitor photoreceptors derived from the directed differentiation of human pluripotent stem cells

  2017cites this paper
• Human Hematopoietic Stem Cells: The Current Understanding and Future Prospects

  2017cites this paper
• Human Hematopoietic Stem Cells: The Current Understanding and Future Prospects Pleurisy as a novel clinical manifestation associated with human herpesvirus 6 after unrelated cord blood transplantation Case report

  2017cites this paper
• Comparison between the Effect of CD34+ Stem Cells and Mesenchymal Stem Cells in Improving Pulmonary Fibrosis in Bleomycin Rat Model

  2016cites this paper
• Automated CD34+ cell isolation of peripheral blood stem cell apheresis product.

  2015cites this paper
• Prospectively defined murine mesenchymal stem cells inhibit Klebsiella pneumoniae-induced acute lung injury and improve pneumonia survival

  2015cites this paper
• Células Madre Hematopoyéticas: origen, diferenciación y función

  2015cites this paper
• Protein Tyrosine Phosphatase Receptor Type S (PTPRS) Regulates Hematopoietic Stem

  2015cites this paper
• Protein Tyrosine Phosphatase Receptor Type S (PTPRS) Regulates Hematopoietic Stem Cell Self-Renewal

  2015cites this paper
• Children with Solid Tumors: Identification of Hematopoietic and Endothelial Progenitor Cells as Biomarkers

  2014cites this paper
• Human CD34-negative Hematopoietic Stem Cells

  2014cites this paper
• Manipulation of Hematopoietic Stem Cells for Regenerative Medicine

  2014cites this paper
• Stem Cells and Cancer Stem Cells, Volume 11

  2014cites this paper
• cells assured by intra-bone marrow injection SCID-repopulating cell activity of human cord blood-derived CD34-negative

  2013cites this paper
• Integrin α2 and Akt in early hematopoiesis

  2013cites this paper
• New approaches to expand hematopoietic stem and progenitor cells

  2012cites this paper
• Epigenetic programming defines stem cell identity and entry into the proliferative compartment in chronic myeloid leukaemia (CML)

  2012cites this paper
• HLA‐haploidentical transplantations for primary immunodeficiencies: A single‐center experience

  2012cites this paper
• Hematopoiesis: a human perspective.

  2012cites this paper
• Long-term results after transplantation of CD34+ selected (CellPro) versus unselected peripheral blood progenitor cells (PBPC) from related allogeneic donors

  2010cites this paper
• Cord and cord blood stem cell tissue engineering for therapeutic intervention in liver disease

  2010cites this paper
• The clinical significance of tumor cells in bone marrow or apheresis product and the efficacy of CD34+ selection and high‐dose chemotherapy in patients with Stage III breast cancer

  2009cites this paper
• D34 Hematopoietic Progenitor Cell Selection of one Marrow Grafts for Autologous Transplantation n Pediatric Patients

  2007influential citation
• CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.

  2007cites this paper
• Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation

  2007cites this paper
• Células madre hematopoyéticas, generalidades y vías implicadas en sus mecanismos de auto-renovación

  2007cites this paper
• Magnetic nanoparticle tagging and application of magnetophoresis to cellular therapy and imaging.

  2006cites this paper
• Hematopoietic Stem Cells

  2006cites this paper
• Myeloma cell contamination of peripheral blood stem-cell grafts can predict the outcome in multiple myeloma patients after high-dose chemotherapy and autologous stem-cell transplantation

  2005cites this paper
• Catalytic Activities of G1 Cyclin‐Dependent Kinases and Phosphorylation of Retinoblastoma Protein in Mobilized Peripheral Blood CD34+ Hematopoietic Progenitor Cells

  2005cites this paper
• Cell tracking velocimetry as a tool for defining saturation binding of magnetically conjugated antibodies

  2005cites this paper
• Autologous haematopoietic-stem-cell transplantation for multiple sclerosis.

  2005cites this paper
• Impaired stem cell function of CD34+ cells selected by two different immunomagnetic beads systems

  2004cites this paper
• Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study.

  2004cites this paper
• SCID-repopulating cell activity of human cord blood-derived CD34- cells assured by intra-bone marrow injection.

  2003cites this paper
• Identification and isolation of hematopoietic stem cells.

  2003cites this paper
• Recent advances in allogeneic hematopoietic stem-cell transplantation.

  2003cites this paper
• Clinical Applications of CD34+ Cell‐selected Peripheral Blood Stem Cells

  2003cites this paper
• Side effects of retroviral gene transfer into hematopoietic stem cells.

  2003cites this paper
• Heterologous cells cooperate to augment stem cell migration, homing, and engraftment.

  2003cites this paper
• Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens

  2002cites this paper
• Bone marrow reconstitution.

  2002cites this paper
• Stem Cell Transplantation for Aggressive Non-Hodgkin ’ s Lymphoma

  2001cites this paper
• Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction.

  2001cites this paper
• Second Transplantation With CD34+ Blood Cells From an HLA-Mismatched Related Donor After Engraftment Failure of Transplanted Cord Blood Cells

  2001cites this paper